Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol ER in chronic knee osteoarthritis pain
NCT00745069Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Jul 2004
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tapentadol in osteoarthritis (OA), sponsored by Johnson & Johnson. Started Jul 2004; status: completed.
02
Drugs
tapentadol
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00745069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00745069.